News
RAPH
1.400
NaN%
--
Raphael Pharmaceutical FY25 net loss narrows 15.79% to USD 1.3 million
Reuters · 03/31 20:04
Raphael Pharmaceutical director Yehuda Eliya exits board as term expires
Reuters · 03/24 20:01
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
Barchart · 11/17/2025 11:03
Weekly Report: what happened at RAPH last week (0908-0912)?
Weekly Report · 09/15/2025 11:51
Raphael Pharmaceutical Inc. Files Initial Statement of Beneficial Ownership for Director Zvi Laufer
Reuters · 09/08/2025 20:29
Weekly Report: what happened at RAPH last week (0901-0905)?
Weekly Report · 09/08/2025 11:53
Weekly Report: what happened at RAPH last week (0825-0829)?
Weekly Report · 09/01/2025 11:47
Weekly Report: what happened at RAPH last week (0818-0822)?
Weekly Report · 08/25/2025 12:01
Weekly Report: what happened at RAPH last week (0811-0815)?
Weekly Report · 08/18/2025 11:51
Raphael Pharmaceutical Inc. Announces Board Changes: Dr. Igal Louria Hayon Resigns, Zvi Laufer Laor Appointed as New Director
Reuters · 08/11/2025 20:08
Weekly Report: what happened at RAPH last week (0804-0808)?
Weekly Report · 08/11/2025 12:00
Weekly Report: what happened at RAPH last week (0728-0801)?
Weekly Report · 08/04/2025 12:03
Weekly Report: what happened at RAPH last week (0721-0725)?
Weekly Report · 07/28/2025 12:03
Weekly Report: what happened at RAPH last week (0714-0718)?
Weekly Report · 07/21/2025 11:51
Weekly Report: what happened at RAPH last week (0707-0711)?
Weekly Report · 07/14/2025 12:03
Weekly Report: what happened at RAPH last week (0630-0704)?
Weekly Report · 07/07/2025 11:52
Weekly Report: what happened at RAPH last week (0623-0627)?
Weekly Report · 06/30/2025 12:00
Weekly Report: what happened at RAPH last week (0616-0620)?
Weekly Report · 06/23/2025 11:50
Weekly Report: what happened at RAPH last week (0609-0613)?
Weekly Report · 06/16/2025 12:00
Weekly Report: what happened at RAPH last week (0602-0606)?
Weekly Report · 06/09/2025 12:01
More
Webull provides a variety of real-time RAPH stock news. You can receive the latest news about Raphael Pharm through multiple platforms. This information may help you make smarter investment decisions.
About RAPH
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company. The Company is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The Company is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.